NCT05737342View on ClinicalTrials.gov

Effect of ANKASCIN 568-P Products on Decreasing HbA1c and Regulating Blood Glucose

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
High Blood SugarMetabolic Syndrome
Interventions
DIETARY_SUPPLEMENT

ANKASCIN 568-P Red yeast rice capsules

Product ingredients: ANKASCIN 568-P red yeast rice product 440 mg,microcrystalline ,cellulose,Maltodextrin; capsule shell composition: HPMC (hydroxypropyl methylcellulose), purified water, titanium dioxide, gellan gum.

DIETARY_SUPPLEMENT

Placebo Capsules

Maltodextrin was used as a placebo

Trial Locations (1)

114202

RECRUITING

Tri-Service General Hospital, National Defense Medical Center, Taipei city,, Taipei

All Listed Sponsors
lead

SunWay Biotech Co., LTD.

INDUSTRY